240 related articles for article (PubMed ID: 26961327)
1. Tenascin C affects mineralization of SaOS2 osteoblast-like cells through matrix vesicles.
Li C; Cui Y; Luan J; Zhou X; Li H; Wang H; Shi L; Han J
Drug Discov Ther; 2016; 10(2):82-7. PubMed ID: 26961327
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-2 inhibits mineralization of osteoblast-like Saos-2 cells by inhibiting the functioning of matrix vesicles.
Liu C; Cui Y; Luan J; Zhou X; Liu Z; Han J
Drug Discov Ther; 2014 Feb; 8(1):42-7. PubMed ID: 24647157
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA of alkaline phosphatase inhibits matrix mineralization.
Kotobuki N; Matsushima A; Kato Y; Kubo Y; Hirose M; Ohgushi H
Cell Tissue Res; 2008 May; 332(2):279-88. PubMed ID: 18317813
[TBL] [Abstract][Full Text] [Related]
4. GPM6B regulates osteoblast function and induction of mineralization by controlling cytoskeleton and matrix vesicle release.
Drabek K; van de Peppel J; Eijken M; van Leeuwen JP
J Bone Miner Res; 2011 Sep; 26(9):2045-51. PubMed ID: 21638316
[TBL] [Abstract][Full Text] [Related]
5. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
[TBL] [Abstract][Full Text] [Related]
6. Long-chain polyphosphate in osteoblast matrix vesicles: Enrichment and inhibition of mineralization.
Li L; Khong ML; Lui ELH; Mebarek S; Magne D; Buchet R; Tanner JA
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):199-209. PubMed ID: 30312769
[TBL] [Abstract][Full Text] [Related]
7. Contribution of osteocalcin-mimetic peptide enhances osteogenic activity and extracellular matrix mineralization of human osteoblast-like cells.
Hosseini S; Naderi-Manesh H; Vali H; Baghaban Eslaminejad M; Azam Sayahpour F; Sheibani S; Faghihi S
Colloids Surf B Biointerfaces; 2019 Jan; 173():662-671. PubMed ID: 30368214
[TBL] [Abstract][Full Text] [Related]
8. 1Alpha,25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles.
Woeckel VJ; Alves RD; Swagemakers SM; Eijken M; Chiba H; van der Eerden BC; van Leeuwen JP
J Cell Physiol; 2010 Nov; 225(2):593-600. PubMed ID: 20506116
[TBL] [Abstract][Full Text] [Related]
9. Annexins A2, A6 and Fetuin-A Affect the Process of Mineralization in Vesicles Derived from Human Osteoblastic hFOB 1.19 and Osteosarcoma Saos-2 Cells.
Bozycki L; Mroczek J; Bessueille L; Mebarek S; Buchet R; Pikula S; Strzelecka-Kiliszek A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924370
[TBL] [Abstract][Full Text] [Related]
10. Mineralization initiation of MC3T3-E1 preosteoblast is suppressed under simulated microgravity condition.
Hu LF; Li JB; Qian AR; Wang F; Shang P
Cell Biol Int; 2015 Apr; 39(4):364-72. PubMed ID: 25318973
[TBL] [Abstract][Full Text] [Related]
11. Phosphatase actions at the site of appositional mineralization in bisphosphonate-affected bones of the rat.
Li Y; Nakayama H; Notani T; Ahmad M; Tabata MJ; Takano Y
J Med Dent Sci; 2008 Sep; 55(3-4):255-65. PubMed ID: 19697513
[TBL] [Abstract][Full Text] [Related]
12. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells.
Müller B; Prante C; Gastens M; Kuhn J; Kleesiek K; Götting C
Matrix Biol; 2008 Mar; 27(2):139-49. PubMed ID: 17980567
[TBL] [Abstract][Full Text] [Related]
14. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells.
Chen NX; O'Neill KD; Chen X; Moe SM
J Bone Miner Res; 2008 Nov; 23(11):1798-805. PubMed ID: 18597635
[TBL] [Abstract][Full Text] [Related]
15. Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells.
Disthabanchong S; Radinahamed P; Stitchantrakul W; Hongeng S; Rajatanavin R
Kidney Int; 2007 Feb; 71(3):201-9. PubMed ID: 17183249
[TBL] [Abstract][Full Text] [Related]
16. The Na
Sheikh IA; Midura-Kiela MT; Herchuelz A; Sokolow S; Kiela PR; Ghishan FK
J Extracell Vesicles; 2024 Jun; 13(6):e12450. PubMed ID: 38859730
[TBL] [Abstract][Full Text] [Related]
17. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation.
Kwun IS; Cho YE; Lomeda RA; Shin HI; Choi JY; Kang YH; Beattie JH
Bone; 2010 Mar; 46(3):732-41. PubMed ID: 19913120
[TBL] [Abstract][Full Text] [Related]
18. Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization.
Roberts S; Narisawa S; Harmey D; Millán JL; Farquharson C
J Bone Miner Res; 2007 Apr; 22(4):617-27. PubMed ID: 17227223
[TBL] [Abstract][Full Text] [Related]
19. Decreased oxygen tension lowers reactive oxygen species and apoptosis and inhibits osteoblast matrix mineralization through changes in early osteoblast differentiation.
Nicolaije C; Koedam M; van Leeuwen JP
J Cell Physiol; 2012 Apr; 227(4):1309-18. PubMed ID: 21604266
[TBL] [Abstract][Full Text] [Related]
20. Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production.
Alves RD; Eijken M; Bezstarosti K; Demmers JA; van Leeuwen JP
Mol Cell Proteomics; 2013 Oct; 12(10):2890-900. PubMed ID: 23781072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
